Pfizer (PFE) raised its annual profit forecast, driven by robust sales in its cancer and heart disease drug segments, particularly benefiting from its recent acquisition of Seagen. The pharmaceutical giant...
Pfizer's transitions from pandemic success to market concerns: analyzing revenue stagnation, investor reactions, and the company's strategic roadmap for growth.
Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.
This heavily sold-off pharma stock is a bargain.
Seattle Genetics: Q3 Earnings Snapshot
The venerable pharmaceutical companies' shares have slumped this year.
/PRNewswire/ -- USA News Group - According to the American Cancer Society in its Cancer Facts & Figures 2023 report, the five-year survival rate for pancreatic...
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END
USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...